Clinical Trial

Single-ascending Dose Study of HEC-151 Injection

Name: Single-ascending Dose Study of HEC-151 Injection — clinical trial record (NCT07376200)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

Evaluate the safety, tolerability, PK/PD and immunogenicity characteristics of a single subcutaneous HEC-151 Injection solution in healthy participants

Protocol Amendment History 2 changes

critical Recruitment opened 2026-04-30

minor Trial arms changed: 2 -> 3 2026-04-30

Trial Details

NCT Number	NCT07376200
Lead Sponsor	Sunshine Lake Pharma Co., Ltd.
Conditions	Healthy Adult Male
Enrollment	81 participants
Start Date	2026-02-24
Primary Completion	2026-09-05 (estimated)
Study Completion	2026-09-27 (estimated)
Updated on ClinicalTrials.gov	2026-04-29